Alnylam Pharmaceuticals
ALNY
#1109
Rank
NZ$38.45 B
Marketcap
NZ$287.09
Share price
5.41%
Change (1 day)
-64.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company